Clinical Trial: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PTT-121

U.S., Aug. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07768176) titled 'A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PTT-121' on Aug. 06.

Brief Summary: This is a Phase I, single-center, randomized, double-blind, placebo-controlled SAD/MAD study to evaluate safety, tolerability, and PK of Intravenously Administered PTT-121 in healthy Chinese adults.

Study Start Date: Aug. 31

Study Type: INTERVENTIONAL

Condition: Healthy Vollunteer

Intervention: DRUG: PTT-121

PTT-121 will be administered intravenously

DRUG: PTT-121 placebo

Matching placebo identical to PTT-121 formulation but without the active pharmaceutical ingredient

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Py...